Physician

Meredith T Overholt, M.D.

According to 2025 Medicare claims, Meredith Overholt, M.D. (NPI: 1801949151) practices dermatology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is SKIN WELLNESS CENTER PC (NPI: 1568515898; TIN: 201654944) and primary practice location at 37922-4609.

Overholt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 910 traditional Medicare patients, billed 7,138 HCPCS/CPT codes, and received $619,263 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 658 prescription claims across 369 beneficiaries totaling $156,536 in drug costs, led by Otezla (Apremilast). 2023 DME data shows 11 claims. Open Payments data shows 64 records totaling $5,006. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $144,317 to $619,263. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $93,685 to $156,536. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	537	3,247	$144,317
2016	559	3,281	$142,017
2017	595	3,337	$142,570
2018	601	4,081	$156,292
2019	667	4,739	$294,664
2020	608	4,748	$310,277
2021	716	5,677	$434,901
2022	748	5,014	$373,926
2023	844	6,928	$580,834
2024	910	7,138	$619,263

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	233	446	$93,685
2016	220	465	$69,859
2017	232	404	$70,437
2018	237	471	$172,239
2019	280	536	$157,248
2020	245	471	$162,251
2021	251	463	$222,019
2022	287	548	$186,247
2023	295	564	$237,475
2024	369	658	$156,536

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$2,588
2023	N/R	11	$2,559
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	306	341	$73
17110	Destruction of skin growth, 1-14 growths	383	484	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	396	478	$54
11102	Biopsy of related skin growth, first growth	211	238	$49
17000	Destruction of precancer skin growth, 1 growth	257	317	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	13	388	$62,868
Dupixent Syringe	Dupilumab	13	364	$46,469
Fluorouracil	Fluorouracil	91	2,613	$6,150
Clobetasol Propionate	Clobetasol Propionate	81	2,108	$3,529
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	27	665	$868

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$5,006	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Meredith T. Overholt, M.D.?

Tedicare shows public-source Medicare data for Meredith T. Overholt, M.D. (NPI 1801949151), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Meredith T. Overholt, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Meredith T. Overholt, M.D.?

Meredith T. Overholt, M.D. is linked to SKIN WELLNESS CENTER PC (billing NPI 1568515898) in the available physician profile data.

Does Meredith T. Overholt, M.D. have Open Payments data?

Meredith T. Overholt, M.D. has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.